High-risk HPV presence in cervical specimens after a large loop excision of the cervical transformation zone: Significance of newly detected hr-HPV genotypes

Journal of Medical Virology

Volumn 79, Issue 3, 2007, Pages 314-319

  Van Ham, Maaike A P C ^a   Van Hamont, Dennis ^a   Bekkers, Ruud L M ^a   Bulten, Johan ^a   Melchers, Willem J G ^a   Massuger, Leon F A G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

High risk HPV; LLETZ

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LARGE LOOP EXCISION OF THE CERVICAL TRANSFORMATION ZONE; MAJOR CLINICAL STUDY; NONHUMAN; PERSISTENT VIRUS INFECTION; RECURRENT DISEASE; SURGICAL TECHNIQUE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERUS SURGERY; VIRUS DETECTION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; BIOPSY; CERVIX UTERI; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INCIDENCE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; UTERINE CERVICAL DISEASES; VAGINAL SMEARS; VIRUS ACTIVATION;

HUMAN PAPILLOMAVIRUS;

EID: 33846799016     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20800     Document Type: Article

References (27)

1. Altekruse SF, Lacey JV, Jr., Brinton LA, Gravitt PE, Silverberg SG, Barnes WA, Jr., Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, et al. 2003. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am J Obstet Gynecol 188:657-663.
2. Bollen LJ, Tjong AHS, van d V, Mol BW, Boer K, ten Kate FJ, Bleker OP, ter SJ. 1997. Clearance of cervical human papillomavirus infection by treatment for cervical dysplasia. Sex Transm Dis 24:456-460.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
4. Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ. 2005. Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 113:1005-1009.
5. Chichareon S, Herrero R, Munoz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJ, Walboomers JM. 1998. Risk factors for cervical cancer in Thailand: A case-control study. J Natl Cancer Inst 90:50-57.
6. Chua KL, Hjerpe A. 1997. Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri. Gynecol Oncol 66:108-113.
7. Clifford GM, Smith JS, Aguado T, Franceschi S. 2003. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 89:101-105.
8. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, Anderson M, Kocjan G, Steele ST, Guillebaud J. 1995. Human papillomavirus testing in primary cervical screening. Lancet 345:1533-1536.
9. Elfgren K, Bistoletti P, Dillner L, Walboomers JM, Meijer CJ, Dillner J. 1996. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens. Am J Obstet Gynecol 174:937-942.
10. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423-428.
11. Keijser KG, Kenemans P, van der Zanden PH, Schijf CP, Vooijs GP, Rolland R. 1992. Diathermy loop excision in the management of cervical intraepithelial neoplasia: Diagnosis and treatment in one procedure. Am J Obstet Gynecol 166:1281-1287.
12. Kjellberg L, Wadell G, Bergman F, Isaksson M, Angstrom T, Dillner J. 2000. Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser. Am J Obstet Gynecol 183:1238-1242.
13. Kleter B, van Doorn LJ, ter SJ, Schrauwen L, van KK, Burger M, ter HB, Quint W. 1998. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 153:1731-1739.
14. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter SJ, Lindeman J, ter HB, Burger M, Quint W. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 37:2508-2517.
15. Lehtinen M, Luukkaala T, Wallin KL, Paavonen J, Thoresen S, Dillner J, Hakama M. 2001. Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction. J Clin Virol 22:117-124.
16. Mann CH, Steele JC, Burton A, Bailey AS, Etherington IJ, Luesley DM. 2001. LLETZ - Evidence of its efficacy against HPV infection. Gynecol Oncol 81:125-127.
17. Melchers WJ, Bakkers JM, Wang J, de Wilde PC, Boonstra H, Quint WG, Hanselaar AG. 1999. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol 155:1473-1478.
18. Munoz N, Bosch FX, de SS, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
19. Nagai Y, Maehama T, Asato T, Kanazawa K. 2000. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: Is it an alarm for disease recurrence? Gynecol Oncol 79:294-299.
20. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study. Lancet 354:20-25.
21. Nobbenhuis MA, Meijer CJ, van den Brule AJ, Rozendaal L, Voorhorst FJ, Risse EK, Verheijen RH, Helmerhorst TJ. 2001. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 84:796-801.
22. Nuovo G, Moritz J, Kowalik A, Chalas E, Kaplan B, Mann W. 1992. Human papillomavirus types and cervical squamous intraepithelial lesions that recur after cold-knife conization. Gynecol Oncol 46:304-308.
23. Parkin DM, Pisani P, Ferlay J. 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594-606.
24. Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, Richart RM, Isacson C. 2000. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 157:1055-1062.
25. Prendiville W, Cullimore J, Norman S. 1989. Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical intraepithelial neoplasia. Br J Obstet Gynaecol 96:1054-1060.
26. van Ham MA, Bakkers JM, Harbers GK, Quint WG, Massuger LF, Melchers WJ. 2005. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: Validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J Clin Microbiol 43:2662-2667.
27. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.